Joleen M. Hubbard
ORCID: 0000-0001-8250-4920Also affiliated with Mayo Clinic in Arizona
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 6 papers. Top paper: “Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial”.
Anita Giobbie‐Hurder, Srinika Ranasinghe, Katrina Kao, Ana Lako, Junko Tsuji +32 more
Tyler Zemla, Joleen M. Hubbard, John H. Strickler, Olumide B. Gbolahan, L. R. Wilson +6 more
Nathan R. Foster, Amit Mahipal, Thomas Byrne, Joleen M. Hubbard, Alvin Silva +4 more
Douglas W. Mahoney, Kelli N. Burger, Patrick H. Foote, Karen A. Doering, William R. Taylor +8 more
Joleen M. Hubbard, Paul J. Novotny, Megan E. Branda, Daniel S. Sargent, Roscoe F. Morton +8 more
Cody Eslinger, Kenneth Lee, Lama F. Farchoukh, Daniel Walden, Oluwadunni Emiloju +13 more